Despite their association with higher tumor grades and LVI, TLSs also correlate with improved disease-free survival in HER2+ breast cancers, suggesting their dual role in tumor aggressiveness and immune surveillance [77]. This evidence concerns the gene ERBB2 and breast cancer.